help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zadik, Z.
Right arrow Articles by Kowarski, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zadik, Z.
Right arrow Articles by Kowarski, A. A.

Journal of Clinical Endocrinology & Metabolism, Vol 71, 1127-1130, Copyright © 1990 by Endocrine Society


ARTICLES

Reproducibility of growth hormone testing procedures: a comparison between 24-hour integrated concentration and pharmacological stimulation

Z Zadik, SA Chalew, Z Gilula and AA Kowarski
Pediatric Endocrine Unit, Kaplan Hospital, Rehovot, Israel.

The purpose of this study was to compare the reproducibility of two approaches to the evaluation of GH secretion: the integrated concentration of GH (IC-GH), a physiological test of GH secretion, and pharmacological stimulation tests. IC-GH was determined in 40 poorly growing children twice within 4 weeks. The first and second IC-GH were highly correlated r = 0.859, P less than 0.001. One hundred and thirteen poorly growing children underwent pharmacological GH stimulation tests twice within 6 weeks. A moderate correlation was found between the first and second pharmacological test r = 0.524, P less than 0.01. Among the three pharmacological stimuli studied, clonidine (n = 81) had the highest reproducibility followed by arginine (n = 20), and insulin (n = 12). We conclude that IC-GH is more consistently reproducible than the GH response to repeated pharmacological stimulation.


This article has been cited by other articles:


Home page
PediatricsHome page
Z. Zadik, T. Sinai, A. Zung, and R. Reifen
Effect of Nutrition on Growth in Short Stature Before and During Growth-Hormone Therapy
Pediatrics, July 1, 2005; 116(1): 68 - 72.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
H K Gleeson and S M Shalet
The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours
Endocr. Relat. Cancer, December 1, 2004; 11(4): 589 - 602.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. K. Gleeson, H. R. Gattamaneni, L. Smethurst, B. M. Brennan, and S. M. Shalet
Reassessment of Growth Hormone Status Is Required at Final Height in Children Treated with Growth Hormone Replacement after Radiation Therapy
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 662 - 666.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
J. J. Bell and K. Dana
Lack of Correlation Between Growth Hormone Provocative Test Results and Subsequent Growth Rates During Growth Hormone Therapy
Pediatrics, August 1, 1998; 102(2): 518 - 520.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
S. M. Shalet, A. Toogood, A. Rahim, and B. M. D. Brennan
The Diagnosis of Growth Hormone Deficiency in Children and Adults
Endocr. Rev., April 1, 1998; 19(2): 203 - 223.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-C. Carel, J.-P. Tresca, M. Letrait, J.-L. Chaussain, Y. Lebouc, J.-C. Job, and J. Coste
Growth Hormone Testing for the Diagnosis of Growth Hormone Deficiency in Childhood: A Population Register-Based Study
J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2117 - 2121.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Tauber, P. Moulin, C. Pienkowski, B. Jouret, and P. Rochiccioli
Growth Hormone (GH) Retesting and Auxological Data in 131 GH-Deficient Patients after Completion of Treatment
J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 352 - 356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society